In Vitro Diagnostics Market Research Reports & Industry Analysis

The publications below represent comprehensive market research on components of the global market for in vitro diagnostics. Reports, published by several different research companies, address financial analyses of major companies, overview analyses of the global market, and specific analyses on individual countries or individual and more specific segments of the market, such as cell analysis.
...Show More ...Show Less


In Vitro Diagnostics Industry Research & Market Reports

  • Non-Invasive Prenatal Testing (NIPT)

    ... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. NIPT Consumables & Reagents, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$5.5 Billion ... Read More

  • Over The Counter (OTC) Testing

    ... Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. Glucose Monitoring Tests, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.7 ... Read More

  • Platelet Rich Plasma (PRP)

    ... 2030, growing at a CAGR of 10.4% over the analysis period 2024-2030. Pure Platelet Rich Plasma, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$833.9 Million ... Read More

  • Hematology Diagnostics

    ... CAGR of 5.8% over the analysis period 2024-2030. Hematology Diagnostic Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.8 Billion by the end of the ... Read More

  • Veterinary Molecular Diagnostics

    ... at a CAGR of 7.5% over the analysis period 2024-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$342.8 Million by the end ... Read More

  • Immunoprotein Diagnostic Testing

    ... at a CAGR of 5.2% over the analysis period 2024-2030. Immunoglobulin Diagnostic Testing, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$6.4 Billion by the end ... Read More

  • Infectious Disease Diagnostics

    ... at a CAGR of 5.5% over the analysis period 2024-2030. Diagnostic Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the ... Read More

  • In-Vitro Diagnostics (IVD) Packaging

    ... 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Bottles, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$4.0 Billion by the end ... Read More

  • Laboratory Automation Workcells

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Laboratory Automation Workcells Hardware & Software, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$2.5 Billion ... Read More

  • Multiplex Detection Immunoassays

    ... at a CAGR of 3.4% over the analysis period 2024-2030. Protein-Based Multiplex Technique, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.4 Billion by the end ... Read More

  • Nucleic Acid Isolation and Purification

    ... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Nucleic Acid Isolation & Purification Kits, one of the segments analyzed in the report, is expected to record a 5.9% CAGR ... Read More

  • Women`s Health Diagnostics

    ... at a CAGR of 5.8% over the analysis period 2024-2030. Breast Cancer Testing, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$11.3 Billion by the end ... Read More

  • Biomedical Refrigerators and Freezers

    ... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Ultra Low Temperature (ULT) Freezers, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$533.2 ... Read More

  • Exocrine Pancreatic Insufficiency

    ... at a CAGR of 5.8% over the analysis period 2024-2030. Exocrine Pancreatic Insufficiency Therapeutics, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.8 Billion by the ... Read More

  • Automated Immunoassay Analyzers

    ... at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence Technology, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of ... Read More

  • Blood Cell Analyzer

    ... at a CAGR of 4.8% over the analysis period 2024-2030. Semi-Automated Biochemistry Analyzers, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$687.6 Million by the end ... Read More

  • Cytology Brushes

    ... CAGR of 6.1% over the analysis period 2024-2030. Metal Brushes, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$71.9 Billion by the end of the analysis ... Read More

  • Pregnancy and Fertility Testing Products

    ... Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 10.7% CAGR The Pregnancy and Fertility ... Read More

  • Immunoassay Systems

    ... CAGR of 3.6% over the analysis period 2024-2030. Immunoassay Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$19.4 Billion by the end of ... Read More

  • Commercial Biotechnology Separation Systems

    ... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Conventional Method, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$19.0 Billion by the ... Read More

  • Testing Laboratories

    ... CAGR of 7.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$30.0 Billion While China is Forecast to Grow at 9.6% CAGR The Testing Laboratories market in the U.S. is estimated at ... Read More

  • COVID-19 Testing

    ... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More

  • Multiplex Assays

    ... CAGR of 6.4% over the analysis period 2024-2030. Multiplex Assay Consumables, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$3.7 Billion by the end of the ... Read More

  • Nucleic Acid Labeling

    ... at a CAGR of 7.5% over the analysis period 2024-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 Billion by the ... Read More

  • Service Laboratories

    ... CAGR of 4.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$31.3 Billion While China is Forecast to Grow at 4.0% CAGR The Service Laboratories market in the U.S. is estimated at ... Read More

Cookie Settings